Skip to main content
OpenTrials

Clinical trial condition

Myasthenia Gravis

Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

264 public trials 97 recruiting studies
Refine in advanced search Browse all conditions

Myasthenia Gravis trial results

Recruiting

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

NCT06607627

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +12 more
Locations
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Norfolk, Virginia, United States
  • Research Site Joinville, Brazil
  • Research Site Salvador, Brazil
View all 13 locations
View Trial Details
Recruiting

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

NCT06626919

Conditions
Autoimmune, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +19 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of California, Irvine Orange, California, United States
  • Stanford Hospital Palo Alto, California, United States
  • University of South Florida - Carol and Frank Morsani Center of Advanced Healthcare Tampa, Florida, United States
View all 13 locations
View Trial Details
Recruiting

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

NCT04202341

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Clinical Trial Site Birmingham, Alabama, United States
  • Clinical Trial Site Scottsdale, Arizona, United States
  • Clinical Trial Site Fresno, California, United States
  • Clinical Trial Site Orange, California, United States
View all 51 locations
View Trial Details
Recruiting

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

NCT04833894

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital Chicago, Illinois, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • University of Virginia (UVA) Health - Developmental Pediatrics Clinic Charlottesville, Virginia, United States
  • Medizinische Universitat Wien Vienna, Austria
View all 25 locations
View Trial Details
Recruiting

A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

NCT06299748

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy, +20 more
Locations
  • United BioSource LLC Morgantown, West Virginia, United States
  • Klinikum der Ruhr-Universität Bochum St. Josef Hospital Neurologische Interdisziplinäre Infusionsambulanz + MS Studienambulanz (Haus E Ebene1) Bochum, Germany
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma, Italy
  • Hospital Universitari Vall d'Hebron Barcelona, Spain
View Trial Details
Recruiting

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

NCT06298565

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center, San Francisco, California, United States
  • SFM Clinical Research, LLC Boca Raton, Florida, United States
  • University of Florida College of Medicine Jacksonville Jacksonville Beach, Florida, United States
  • Medsol Clinical Research Center Inc Port Charlotte, Florida, United States
View all 35 locations
View Trial Details

Related conditions